From CTV News:
Researchers in Calgary are preparing to begin a new study to see whether a commonly available acne medication could help delay the crippling effects of multiple sclerosis.
The medication, called minocycline, has been available for over 30 years. If it's proven effective in delaying the progress of MS, it could offer an inexpensive option for the treatment of early stages of the disease.
A small study on 10 patients a few years ago yielded promising results. Now, clinical researchers in 14 Canadian centres will be taking an in-depth look at the drug in a $4-million, two-year study funded by the MS Society of Canada.
Minocycline is a prescription antibiotic used to control acne by killing the germs that prompt outbreaks. But the drug also offers anti-inflammatory properties, which researchers believe are responsible for its ability to slow the progress of MS. ...more
Monday, October 29, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment